Study on the biochemical basis of mefloquine resistant Plasmodium falciparum

Experimental Parasitology

Volumn 117, Issue 2, 2007, Pages 141-148

  Na Bangchang, Kesara ^a   Bray, Patrick G ^b   Ward, Steven A ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b Division of Molecular and Biochemical Parasitology of Liverpool   (United Kingdom)

Author keywords

Mefloquine; Metabolism; Plasmodium falciparum

Indexed keywords

CARBON 14; CARBOXYMEFLOQUINE; MEFLOQUINE; UNCLASSIFIED DRUG;

ARTICLE; BIOTRANSFORMATION; CHEMICAL ANALYSIS; DETOXIFICATION; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; ISOTOPE LABELING; LIVER MICROSOME; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANIMALS; ANTIMALARIALS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG RESISTANCE; ERYTHROCYTES; INHIBITORY CONCENTRATION 50; MEFLOQUINE; NADP; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 34548357138     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2007.04.002     Document Type: Article

References (40)

1. Agosin M., Cherry A., Pedemonte J., and White R. Cytochrome P450 in culture forms of Trypanosoma cruzi. Comp. Biochem. Phys. 78C (1984) 127-132
2. Awasthi A., Dutta G.P., Bhakuni V., and Tripathi R. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis. Exp. Parasitol. 107 (2004) 115-119
3. Basco L.K., Gillotin C., Gimenez F., Farinotti R., and Le Bras J. Absence of antimalarials activity or interaction with mefloquine enantiomers in vitro of the main human metabolite of mefloquine. Trans. R. Soc. Trop. Med. Hyg. 85 (1991) 208-209
4. Basco L.K., Gillotin C., Gimenez F., Farinotti R., and Le Bras J. In vitro activity of the enantiomers of mefloquine, halofantrine and winproline against Plasmodium falciparum. Br. J. Clin. Pharmacol. 33 (1992) 517-520
5. Berger B.J., Martiney J., Slater A.F.G., Fairlamb A.H., and Cerami A. Chloroquine resistance is not associated with drug metabolism in Plasmodium falciparum. J. Parasitol. 81 (1995) 1004-1008
6. Bitoni A.J., Sjoerdsma A., McCann P.P., Kyle D.E., Oduola A.M.J., Rossan R.N., Milhous W.K., and Davidson D.E. Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine. Science 242 (1988) 1301-1303
7. Bray P.G., Mungthin M., Hastings I.M., Biagini G.A., Saidu D.K., Lakshmanan V., Johnson D.J., Hughes R.H., Stocks P.A., O'Neill P.M., Fidock D.A., Warhurst D.C., and Ward S.A. PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX. Mol. Microbiol. 62 (2006) 238-251
8. Chevli R., and Fitch C.D. The antimalarials drug mefloquine binds to membrane phospholipids. Antimicrob. Agents Chemother. 21 (1982) 581-586
9. Churchill F.C., Mount D.L., Patchen L.C., and Bjorkman A. Isolation, characterization and standardization of a major metabolite of amodiaquine by chromatographic and spectroscopic means. J. Chromatogr. 377 (1986) 307-318
10. Desjardins R.E., Canfield C.P., Haynes J.D., and Chulay J.D. Quantitative assessment of antimalarials activity in vitro by a semi-automated microdilution technique. Antimicrob. Agents Chemother. 16 (1979) 710-718
11. Duffy P.E., and Mutabingwa T.K. Artemisinin combination therapies. Lancet 367 9528 (2006) 2037-2039
12. Erikkson B., Lebbad M., and Bjorkman A. In vitro activity of proguanil, cycloguanil and their main metabolites against Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 83 (1989) 438
13. Fitch C.D., Chan R.L., and Chevli R. Chloroquine resistance in malaria: accessibility of drug receptors to mefloquine. Antimicrob. Agents Chemother. 15 (1979) 258-262
14. Fitch C.D. Ferriprotoporphyrin IX, phospholipdis, and the antimalarials actions of quinoline drugs. Life Sci. 74 (2004) 1957-1972
15. Fontaine F., de Sousa G., Burcham P.C., Duchne P., and Rashmani R. Role of cytochrome P450 3A in the metabolism of mefloquine in human and animal hepatocytes. Life Sci. 66 22 (2000) 2193-2212
16. Ginsburg H., and Demel K.A. Interactions of hemin, antimalarials drugs and hemin-antimalarial complexes with phospholipids monolayers. Chem. Phys. Lipids 35 (1984) 331-347
17. Gupta S., Srivastava D.K., Verma V., and Shukla O.P. Drug metabolizing enzymes and cytochromes of Acanthamoeba culbertsoni. Indian J. Parasitol. 7 (1983) 175-177
18. Krogstad D.J., Gluzman I.Y., Kyle D.E., Oduola A.M., Martin S.K., Milhous W.K., and Schilessinger P.H. Efflux of chlroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238 (1987) 1283-1285
19. Lowry D.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
20. Martin A.S.K., Oduola A.M.J., and Mihous W.K. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235 (1987) 599-602
21. Mockenhaupt F.P., Bedu-Addo G., Junge C., Hommerich L., Eggelte T.A., and Bienzle U. Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women. Antimicrob. Agents Chemother. 51 1 (2007) 332-334
22. Na-Bangchang K., Karbwang J., and Back D.J. Mefloquine metabolism by human liver microsomes. Biochem. Pharmacol. 43 (1992) 1957-1961
23. Ndifor A.M., Ward S.A., and Howells R.E. Cytochrome P450 activity in malarial parasites and its possible relationship to chloroquine resistance. Mol. Biochem. Parasitol. 41 (1990) 251-258
24. Ndifor A.M., Howells R.E., Bray P.G., Ngu J.L., and Ward S.A. Enhancement of drug susceptibility of Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors. Antimicrob. Agents Chemother. 37 (1993) 1318-1323
25. Oduola A.M.J., Omitowoju G.O., Gerena L., Kyle D.E., Milhous W.K., Sowunmi A., and Salako L.A. Reversal of mefloquine resistance with penfluridol in isolates of Plasmodium from Southwest Nigeria. Trans. R. Soc. Trop. Med. Hyg. 87 (1993) 81-83
26. Omura T., and Sato R. The carbon-monoxide binding pigment of liver microsomes. J. Biol. Chem. 239 (1967) 2370-2378
27. Pandey V.C., Saxena N., Bass S.K., Dutta G.P., and Ghatak S. Cytochrome P450 in Plasmodium knowlsei, a simian malarial parasite. IRCS Med. Sci. 14 (1986) 346-347
28. Pham Y.T., Nosten F., Farinotti R., White N.J., and Giminez F. Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria. Intern. J. Clin. Pharmacol. Ther. 37 (1999) 58-61
29. Rabinovich S.A., Kulikovskaya I.M., Maksakovskaya E.V., Pankova T.G., and Salganik R.I. Suppression of the chloroquine resistance of Plasmodium berghei by treatment of infected mice with a microsomal monooxygenase inhibitor. Bull WHO 65 (1987) 387-389
30. Riffkin C.D., Chung R., Wall D.M., Zalcberg J.R., Cowman A.F., Foley M., and Tilley L. Modulation of the function of human MDR1 P-glycoprotein by the antimalarials drug mefloquine. Biochem. Pharmacol. 52 (1996) 1545-1552
31. Rohrbach P., Sanchez C.P., Hayton K., Friedrich O., Patel J., Sidhu A.B., Ferdig M.T., Fidock D.A., and Lanzer M. Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum. EMBO J. 25 13 (2006) 3000-3011
32. Roll Back Malaria, World Health Organization, and United Nationals Children's Fund (UNICEF). World Malaria Report 2005. Report no. WHO/HTM/MAL/2005.1102. http://rbm.who.int/wmr, 2005.
33. Salganik R.I., Pankova T.G., Chekhonadskikh T.V., and Igonina T.M. Chloroquine resistance of Plasmodium berghei: biochemical basis and countermeasures. Bull WHO 65 (1987) 381-386
34. San George R.C., Nagel R.L., and Fabryl M.E. On the mechanism for the red cell accumulation of mefloquine: an antimalarials drug. Biochem. Biophys. Acta 803 (1984) 174-181
35. Surolia N., Karthkeyan G., and Padmanaban G. Involvement of cytochrome P450 in conferring chloroquine resistance to the malarial parasite Plasmodium falciparum. Biochem. Biophys. Res. Commun. 197 (1993) 562-569
36. Trager W., and Jensen J.B. Plasmodium falciparum in culture: use of outdated erythrocytes and description of the candle jar method. J. Parasitol. 63 (1977) 883-886
37. Tripathi R., Awasthi A., and Dutta G.P. Mefloquine resistance reversal action of ketoconazole - a cytochrome P450 inhibitor, against mefloquine-resistant malaria. Parasitology 130 5 (2005) 475-479
38. Vandekooi G., Prapunwattana P., and Yuthavong Y. Evidence for electrogenic accumulation of mefloquine by malarial parasites. Biochem. Pharmacol. 37 (1988) 3623-3631
39. Vidrequin S., Gimenez F., Basco L.K., Martin C., LeBras J., and Farinotti R. Uptake of mefloquine enantiomers into uninfected and malaria-infected erythrocytes. Drug Metab. Dispos. 24 6 (1996) 689-691
40. Warhurst D.C. An antimalarials drugs: an update. Drugs 33 (1987) 50-65